Skip to main content

Peer Review reports

From: The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy

Original Submission
28 Mar 2011 Submitted Original manuscript
17 May 2011 Reviewed Reviewer Report - Kazuyuki Kawakami
25 May 2011 Reviewed Reviewer Report - Megan Hitchins
30 May 2011 Reviewed Reviewer Report - Wei-Peng Yong
28 Jun 2011 Author responded Author comments - Byung-Hoon Min
Resubmission - Version 2
28 Jun 2011 Submitted Manuscript version 2
13 Jul 2011 Reviewed Reviewer Report - Megan Hitchins
16 Jul 2011 Reviewed Reviewer Report - Kazuyuki Kawakami
26 Jul 2011 Author responded Author comments - Byung-Hoon Min
Resubmission - Version 3
26 Jul 2011 Submitted Manuscript version 3
Publishing
10 Aug 2011 Editorially accepted
10 Aug 2011 Article published 10.1186/1471-2407-11-344

You can find further information about peer review here.

Back to article page